Health Care & Life Sciences » Biotechnology | Northwest Biotherapeutics Inc.

Northwest Biotherapeutics Inc.

Northwest Biotherapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.17
Market Cap
$137.75 M
Shares Outstanding
544.47 M
Public Float
504.11 M

Profile

Address
4800 Montgomery Lane
Bethesda Maryland 20814
United States
Employees -
Website http://www.nwbio.com
Updated 07/08/2019
Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines.

Financials

View All

Linda F. Powers
Chairman, President & Chief Executive Officer
Alton L. Boynton
Secretary, Director & Chief Scientific Officer